Psicodol

Selected form

Haloperidol

Method of action: Antiemetic, Antipsychotic, Sedative

Treatment option: Dementia With Depressive Features, Depressive Psychosis, ADHD In Children, Tourette Syndrome, Nausea/Vomiting, Schizophrenia

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Psicodol

Property	Description
Active ingredient	Haloperidol
Forms	Tablet, Oral Concentrate, Injection
Pharmacological class	First-Generation Antipsychotic (FGA)
Common purpose	Calming severe psychological distress
Origin	Synthetic compound

Psicodol: Identity and Pharmacological Classification

Psicodol is a definitive, prescription-only medication whose active ingredient is the potent chemical substance Haloperidol. This medicine is classified as a First-Generation Antipsychotic (FGA), often referred to as a typical or conventional antipsychotic agent, belonging to the butyrophenone chemical class. Haloperidol is a compound of synthetic origin and is recognized by the World Health Organization (WHO) as an essential medicine. The efficacy and profile of Haloperidol are documented through pharmacological research regarding its application in managing acute psychological conditions.

Composition, Forms, and General Therapeutic Purpose

Psicodol is consistently a single-ingredient product, centered on the active substance Haloperidol, but is formulated to facilitate different administration routes. It is available in various dosage form(s), including oral tablets, an oral concentrate (liquid), and a parenteral solution for intramuscular administration. The active compound may be prepared as Haloperidol lactate, used for short-acting, aqueous injections, or as Haloperidol decanoate, which is suspended in an oil-based vehicle to create an extended-release injection. The general therapeutic purpose of this medication is to help stabilize brain activity by functioning as a high-affinity Dopamine D2 receptor antagonist. This mechanism acts on central nervous system activity associated with severe behavioral dysregulation and abnormal excitement. This action also contributes to its capability as an effective antiemetic agent against severe nausea and vomiting.

Regulatory References

What side effects are possible with Psicodol?

Possible Side Effects and Safety Information

The safety profile of Psicodol is derived strictly from government regulatory documentation, including official classifications of adverse reactions by frequency and affected body system.

Common and Expected Adverse Reactions

Adverse reactions are classified by frequency based on clinical trial data. Very Common (ge 10% incidence) side effects documented in the regulatory labeling include somnolence, increased appetite, fatigue, and upper respiratory tract infection. Common (ge 1% to <10% incidence) reactions include symptoms of Parkinsonism, tremor, akathisia, dizziness, weight gain, and nausea.

System-Organ-Class (SOC) Groupings

Side effects are categorized by the systems they affect. Key System-Organ-Classes listed in the regulatory documents include Nervous System Disorders (e.g., movement disorders like extrapyramidal symptoms), Metabolism and Nutrition Disorders (e.g., weight gain, hyperglycemia), and Endocrine Disorders (e.g., hyperprolactinemia).

Serious Adverse Reactions and Restrictions

Regulatory agencies assign specific warnings to serious, clinically significant risks. A Boxed Warning exists regarding increased mortality when the drug is used in elderly patients with dementia-related psychosis; the drug is not approved for this use. Other serious documented risks include Neuroleptic Malignant Syndrome (NMS), Tardive Dyskinesia, and serious blood disorders such as agranulocytosis. Caution is required when prescribing to patients with a history of seizures or those with cardiovascular disease. Additionally, a lower starting dose is required for patients with documented severe hepatic or renal impairment.

Overdose and Emergency Response

Overdose: When to Seek Help

Overdose with Psicodol (Risperidone) requires immediate medical attention. The symptoms of an overdose are generally an exaggeration of the drug's known effects, primarily affecting the central nervous and cardiovascular systems.

Documented Overdose Symptoms

The most frequently reported clinical manifestations include drowsiness, severe sedation, rapid heart rate (tachycardia), and low blood pressure (hypotension). Other severe presentations reported are extrapyramidal symptoms (such as unusual, involuntary movements of the face and body), convulsions (seizures), and an altered electrical rhythm of the heart, specifically a prolonged QT interval.

Required Emergency Action

If an overdose is suspected, seek emergency medical care immediately or contact a certified poison control center. Treatment involves supportive care with continuous medical supervision. Essential steps include ensuring an adequate airway and ventilation, and continuously monitoring cardiac rhythm and vital signs until recovery. Specific management for severe extrapyramidal symptoms typically involves the administration of anticholinergic medication. Hypotension is treated with intravenous fluids and, if needed, specific pressor agents, though the use of epinephrine and dopamine is generally advised against due to potential for worsened low blood pressure.

Overdose Presentations (High-Level)	Manifestations (Regulatory-derived)
CNS Depression	Drowsiness, sedation, convulsions, altered level of consciousness.
Cardiovascular Effects	Tachycardia, hypotension, prolonged QT/widened QRS.
Movement Disorders	Extrapyramidal symptoms, dystonic reactions.

Therapeutic Uses of Psicodol

Psicodol may be part of symptomatic management across several key clinical domains, primarily focusing on conditions marked by severe, disruptive mental and physical manifestations. Formal therapeutic indications are established for contexts involving heightened systemic burden and distressing manifestations. It may assist with helping patients cope more steadily with difficult episodes.

Psicodol is commonly used across conditions presenting with acute episodes and for long-term supportive care. The medication is relevant for easing symptoms related to psychotic disorders (such as schizophrenia and acute mania), severe tic disorders (like Tourette's syndrome), profound agitation and aggression, and intractable nausea and vomiting. It helps address symptom clusters that may become intense or disruptive, such as hallucinations, delusions, thought disorganization, or involuntary motor and vocal tics. By providing support that helps ease the overall symptom burden, the medication contributes to improved comfort during phases of increased distress.

“Psicodol is relevant when supportive symptom management is appropriate, particularly in situations where symptoms become temporarily overwhelming.”

Quick Fact: Relief for Acute Agitation Psicodol is commonly used in clinical settings that involve acute or unstable symptom patterns, such as a psychotic crisis, where the primary benefit is the relief of severe aggression or hyperactivity.

Eligibility and Restrictions for Use

Who Can and Cannot Use Psicodol? (Official Regulatory Information)

Official regulatory documents define specific populations for whom the use of Psicodol is restricted or prohibited based on established safety and efficacy data. This information is derived from sections like Contraindications and Use in Specific Populations.

Eligibility Status	Description (Based on Regulatory Labeling)
Contraindicated	Use is strictly prohibited for patients with a known hypersensitivity to Psicodol or its excipients. It is also contraindicated in elderly patients with dementia-related psychosis due to documented increased mortality risk.
Restricted Use	Patients with severe renal or hepatic impairment, as well as the elderly or debilitated, require conditional use starting with a lower initial dose and slower titration schedule.
Age-Related	Efficacy and safety are not established for treating Schizophrenia in children under 13 years of age or for Bipolar I Mania in children under 10 years of age, restricting use below these specific age limits.
Reproductive Status	Use is not recommended for nursing mothers as the drug is excreted in human milk. During pregnancy, use is permitted only if the potential benefit outweighs the risk to the fetus, particularly in the third trimester.

Eligibility is conditional on the patient's age, specific diagnosis, and physiological state. These limitations ensure the drug is used only in populations where its profile is deemed safe and effective by governing health authorities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Psicodol's interaction profile outlines specific constraints and requirements when co-administered with other substances, based on official regulatory documentation.

Pharmacokinetic and Pharmacodynamic Interactions

The co-administration of Psicodol with certain products can lead to changes in its concentration in the body or result in additive effects on the nervous or cardiovascular systems. Enzyme Inducers, such as Carbamazepine, are documented to decrease the plasma concentrations of Psicodol. Conversely, strong CYP 2D6 Inhibitors, including Fluoxetine and Paroxetine, are reported to increase Psicodol’s concentrations.

From a physiological standpoint, co-administration with other Centrally-Acting Drugs requires caution due to additive central nervous system (CNS) depressant effects. The combination with hypotensive agents may enhance hypotensive effects. Furthermore, the effects of dopamine agonists, such as Levodopa, may be antagonized by Psicodol.

Mechanism of Action

Regulation of Receptor-Mediated Signaling

Psicodol acts by engaging mechanisms that modulate specific signaling processes, specifically targeting receptor- or enzyme-mediated signaling within the nervous system. This action modifies early molecular steps that determine systemic physiological outcomes.

Modulation of Key Pathway Activity

The compound influences pathway activity to achieve a specific level of molecular signaling by affecting systems where specific transmitters or mediators dominate. This involves initiating or suppressing signaling sequences that lead to downstream physiological effects and attenuates the signaling output resulting from high mediator activity.

Influence on Feedback Regulation in Cascades

Psicodol interacts with biological cascades where multiple layers of pathway activation occur, engaging mechanisms that influence feedback regulation within those pathways. This effect alters the magnitude of physiological signaling output and induces a downstream physiological consequence defined by its specific mechanistic action.

Dosage and Administration Information

Administration of Psicodol

Psicodol is typically administered orally. The medication is available in tablet form and should be taken according to the specific schedule determined by a healthcare provider. It is common for the medication to be taken with water, and it can generally be consumed either with or without food, depending on individual tolerance and professional advice.

Consistency in Use

For the medication to be effective, it is important to maintain a consistent routine. Taking the tablets at the same time each day helps keep a steady level of the active ingredient in the bloodstream. If a dose is missed, it is generally recommended to skip the missed dose and return to the regular schedule rather than taking two doses at once.

Handling and Storage

Tablets should be swallowed whole and not crushed, chewed, or broken unless specifically advised otherwise. Proper storage is essential to maintain the integrity of the medication:

Store the medication at room temperature.
Keep the container tightly closed when not in use.
Protect the tablets from excessive moisture and direct light.
Store in a secure location away from the reach of children and pets.

Duration of Use

The duration of use is determined on an individual basis. It is standard practice to continue the regimen for the full period prescribed, even if symptoms appear to improve early in the process. Any adjustments to the routine or the discontinuation of the medication should occur under the guidance of a healthcare professional to ensure the process is managed appropriately.

Recent Clinical Evidence

Psicodol: Recent Clinical Evidence

Clinical research has focused on the safety and efficacy of Psicodol (which corresponds to risperidone) across its approved indications, including schizophrenia, bipolar I disorder, and irritability associated with autism spectrum disorder (ASD).

Efficacy Findings

Studies in adult and adolescent patients with schizophrenia have indicated that treatment with Psicodol is associated with reduction in overall symptom severity compared to placebo, particularly concerning positive symptoms such as delusions and hallucinations. Similarly, for acute manic or mixed episodes associated with bipolar I disorder, evidence suggests a beneficial effect on mood stabilization and reduction of manic symptoms.

In children and adolescents with ASD, clinical trials supported the observation that Psicodol was effective in managing severe behavioral issues, including aggression, self-injury, and temper tantrums.

Safety and Tolerability

Psicodol is associated with a range of side effects, and caution is advised. Common adverse events reported in clinical trials include somnolence, weight gain, and extrapyramidal symptoms (EPS), the incidence of which may be dose-dependent. In comparative studies, Psicodol's tolerability profile was noted to be different from first-generation antipsychotics.

A critical warning has been issued concerning an increased risk of stroke and death when Psicodol is used in elderly patients with dementia-related psychosis. This patient population is often excluded from or requires specialized monitoring during treatment with this class of medication.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Psicodol (FAQ)

Q: What kind of medicine is Psicodol and what is it used for?

Psicodol is classified as an atypical antipsychotic medicine. According to official product information, it is indicated for the treatment of certain mental health conditions, including schizophrenia and bipolar disorder. The medicine works by affecting the balance and communication of chemical neurotransmitters in the brain.

Q: Can Psicodol be used long-term?

Regulatory documents state that Psicodol is used for the acute and maintenance treatment of schizophrenia and bipolar disorder. Its use for maintenance treatment, as indicated in regulatory documents, means it may be prescribed for extended periods; the exact duration should be determined by the treating physician.

Q: How long does it take for Psicodol to start working?

Official information indicates that Psicodol generally begins to exert its therapeutic effects gradually over several weeks of consistent use. The time until a beneficial effect is noticed can vary significantly between individuals and depends on the specific condition being treated.

Q: What should I do if I miss a dose of Psicodol?

Regulatory product information typically states that a missed dose may be taken when remembered, unless it is already almost time for the next scheduled dose. If that is the case, the missed dose is usually skipped. Official guidance warns against taking a double dose to compensate for the missed one.

Q: Does Psicodol cause weight gain?

Studies and official information indicate that weight gain is a commonly reported potential side effect associated with Psicodol. This effect is noted in the official documentation as a common metabolic change associated with this class of medication.

Q: Is it safe to drive while taking Psicodol?

According to the official product information, Psicodol can cause side effects such as dizziness, drowsiness, and blurred vision. These effects may impair a person's ability to drive or operate machinery safely. Regulatory documents recommend exercising caution, especially initially, as the medicine's full effect on alertness is established.

Q: Can I drink alcohol while taking Psicodol?

Regulatory documents strongly advise against the consumption of alcohol while taking this medicine. Alcohol can increase the sedative effects of Psicodol, which may lead to excessive drowsiness and a worsening of central nervous system effects.

Q: How should Psicodol be stored?

Official product information states that Psicodol should be stored at room temperature, kept in its original packaging, and protected from excessive moisture and heat. It is essential to keep the medicine secured and out of the sight and reach of children and pets.

How should Psicodol be stored and disposed of?

How to Store and Dispose of Psicodol: Official Requirements

Storage Conditions

Psicodol must be stored at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). It is essential to keep the medicine in its original container and keep the container tightly closed to protect the contents from moisture and maintain product stability. Avoid storing the medication in areas of excessive heat or high humidity, and do not freeze.

Child Safety and Disposal

For safety, keep Psicodol out of the reach of children and store it in a secure location. To dispose of unused or expired medicine, the official regulatory guidance requires the use of a drug take-back program or an authorized collection point. Do not dispose of this medication by flushing it down a toilet or pouring it down a sink unless the product labeling specifically instructs this method.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.